RÁČIL, Zdeněk, Lucie BUREŠOVÁ, Martin BREJCHA, Jiřina PROCHÁZKOVÁ, René ZOUNAR, Shira TIMILSINA, Filip RÁZGA, Martina TOŠKOVÁ, Petr CETKOVSKÝ and Jiří MAYER. Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients. American Journal of Hematology. Wiley-Blackwell, 2011, vol. 86, No 9, p. 800-803. ISSN 0361-8609. Available from: https://dx.doi.org/10.1002/ajh.22100.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients
Name in Czech Klinické a laboratorní charakteristiky leukémií v době diagnozy: Analýza 1,004 po sobě jdoucích pacientů
Authors RÁČIL, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), Lucie BUREŠOVÁ (203 Czech Republic, belonging to the institution), Martin BREJCHA (203 Czech Republic), Jiřina PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), René ZOUNAR (203 Czech Republic), Shira TIMILSINA (524 Nepal, belonging to the institution), Filip RÁZGA (703 Slovakia, belonging to the institution), Martina TOŠKOVÁ (703 Slovakia, belonging to the institution), Petr CETKOVSKÝ (203 Czech Republic) and Jiří MAYER (203 Czech Republic, belonging to the institution).
Edition American Journal of Hematology, Wiley-Blackwell, 2011, 0361-8609.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.671
RIV identification code RIV/00216224:14740/11:00053037
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/ajh.22100
UT WoS 000295003800019
Keywords in English Clinical laboratory features; leukemia analysis
Tags ok, rivok
Tags International impact
Changed by Changed by: Olga Křížová, učo 56639. Changed: 3/4/2012 02:16.
Abstract
To determine the major presenting features of the most frequent leukemias and to describe the period from the first symptoms to the final diagnosis, we analyzed the records of 1,004 consecutive patients with acute (AL) and chronic (CL) leukemias diagnosed between 2004 and 2009. In 24% of AL and 63% of CL, the diagnosis was made incidentally. In contrast to the frequency of the symptoms, their spectrum did not differ from historical studies, and fatigue and weakness were the most frequent symptoms observed [with the exception of acute promyelocytic leukemia (APL) where bleeding predominated]. More profound cytopenia was found in AL compared to CL. The median time from the first symptoms to final diagnosis was 3 weeks in AL and 4 weeks in CL. APL had the shortest time to a definitive diagnosis (2 weeks); however, a very short duration of symptoms was also observed in CML (3 weeks). This study is the largest series reported to date on symptoms in leukemia patients at the time of diagnosis, and the first such report that reflects on clinical practice in the new millennium.
Abstract (in Czech)
Za účelem určit hlavní rysy nejčastějších leukémií a popis období od prvních příznaků do finální diagnózy, jsme analyzovali záznamy od 1004 po sobě jdoucích pacientů s akutní (AL) a chronickou (CL) leukémií diagnostikovaných v letech 2004 až 2009.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 26/4/2024 13:02